Authors:
Hasinoff, BB
Abram, ME
Barnabe, N
Khelifa, T
Allan, WP
Yalowich, JC
Citation: Bb. Hasinoff et al., The catalytic DNA topoisomerase II inhibitor dexrazoxane (ICRF-187) induces differentiation and apoptosis in human leukemia K562 cells, MOLEC PHARM, 59(3), 2001, pp. 453-461
Citation: T. Khelifa et Wt. Beck, Merbarone, a catalytic inhibitor of DNA topoisomerase II, induces apoptosis in CEM cells through activation of ICE/CED-3-like protease, MOLEC PHARM, 55(3), 1999, pp. 548-556
Authors:
Khelifa, T
Rene, B
Le Mee, S
Lambert, B
Saucier, JM
Markovits, J
Jacquemin-Sablon, H
Jacquemin-Sablon, A
Citation: T. Khelifa et al., Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblastswith human topoisomerase II alpha cDNA: Selective restoration of the sensitivity to DNA religation inhibitors, CANCER RES, 59(19), 1999, pp. 4927-4936
Citation: T. Khelifa et Wt. Beck, Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells, BIOCH PHARM, 58(8), 1999, pp. 1247-1257